Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS

Acquisitions

▤ Summary

PITTSBURGH--(BUSINESS WIRE)--Evoqua Water Technologies (NYSE: AQUA), an industry leader in mission-critical water treatment solutions, today announced the closing of the previously announced acquisition of the renal business historically operated by Mar Cor Purification and Cantel Medical, subsidiaries of STERIS Plc (NYSE: STE). Mar Cor offers significant technical expertise in designing, building, and servicing high-purity water treatment systems to an installed base of approximately 5,500 sites. "With the close of this transaction, Evoqua is well-positioned to expand our service footprint in North America to provide proven water solutions for the healthcare industry." These and other important factors may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements, including, but not limited to, those risks and uncertainties discussed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, and in other filings, we may make from time to time with the Securities and Exchange Commission. We present adjusted EBITDA because we believe it is frequently used by analysts, investors, and other interested parties to evaluate and compare operating performance and value companies within our industry.

▥ Classifications

industries
No industries detected
applications
E-Commerce & Retail

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies